Published April 3, 2023 | Version v3

Assessment of covalently binding warhead compounds in the validation of the cytomegalovirus nuclear egress complex as an antiviral target

Description

Supplementary to the publication:

"Assessment of covalently binding warhead compounds in the validation of the cytomegalovirus nuclear egress complex as an antiviral target" (2023), published in Cells

Raw images of the Figures 4, 10, 11 and 14

Notes

This research of herpesviral nuclear egress and the development of antiviral small molecues was funded by Deutsche Forschungsgemeinschaft/DFG (German Research Foundation–401821119, Research Training Group GRK2504 for M.M. and J.T.), DFG (grant MA1289/11-1/11-3), Bayerische Forschungsstiftung (grant DeeP-CMV/AP-5/M.M.), and Volkswagenstiftung (grant Az9B783).

Files

Tillmanns et al_2023.zip

Files (33.4 MB)

Name Size Download all
md5:452972fca132da5298d20768dbed9e3e
33.4 MB Preview Download